Track the Q BioMed Inc. share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Operating in the Health Care sector, Q BioMed Inc. has logged 2 insider filings. The latest transaction was disclosed on 31 May 2022 (Attribution). Among the most active insiders: Corin Denis. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Q BioMed Inc. 是一家生物技术公司,专注于开发和商业化用于治疗严重疾病的药物产品。它旨在通过创新解决方案改善患者的生活质量。